Across Cancer Types

We are committed to our focus disease areas of lung and gastrointestinal cancers but are guided by science and pursue opportunities in other areas of unmet need, to deliver first-in-class treatments that can transform patient lives.  Our commitment to innovation has already resulted in pioneering treatments and we are advancing a unique pipeline of cancer cell directed agents, immuno-oncology therapies and combination approaches to help win the fight against cancer.